Search Results

There are 46034 results for: content related to: Oncogenic activation of glypican-3 by c-Myc in human hepatocellular carcinoma

  1. Glypican-3: A promising biomarker for hepatocellular carcinoma diagnosis and treatment

    Medicinal Research Reviews

    Fubo Zhou, Wenting Shang, Xiaoling Yu and Jie Tian

    Version of Record online : 16 JUN 2017, DOI: 10.1002/med.21455

  2. You have full text access to this Open Access content
    Glypican 3-expressing gastric carcinoma: Distinct subgroup unifying hepatoid, clear-cell, and α-fetoprotein-producing gastric carcinomas

    Cancer Science

    Volume 100, Issue 4, April 2009, Pages: 626–632, Tetsuo Ushiku, 1 Hiroshi Uozaki, 1 Aya Shinozaki, 1 Satoshi Ota, 1 Keisuke Matsuzaka, 1 Sachiyo Nomura, 2 Michio Kaminishi, 3 Hiroyuki Aburatani, 4 Tatsuhiko Kodama and 4 Masashi Fukayama 1,5

    Version of Record online : 19 FEB 2009, DOI: 10.1111/j.1349-7006.2009.01108.x

  3. You have free access to this content
    Glypican-3, overexpressed in hepatocellular carcinoma, modulates FGF2 and BMP-7 signaling

    International Journal of Cancer

    Volume 103, Issue 4, 10 February 2003, Pages: 455–465, Yutaka Midorikawa, Shumpei Ishikawa, Hiroko Iwanari, Takeshi Imamura, Hirohiko Sakamoto, Kohei Miyazono, Tatsuhiko Kodama, Masatoshi Makuuchi and Hiroyuki Aburatani

    Version of Record online : 21 NOV 2002, DOI: 10.1002/ijc.10856

  4. Gefitinib inhibits the cross-talk between mesenchymal stem cells and prostate cancer cells leading to tumor cell proliferation and inhibition of docetaxel activity

    Journal of Cellular Biochemistry

    Volume 114, Issue 5, May 2013, Pages: 1135–1144, Cinzia Borghese, Lara Cattaruzza, Eliana Pivetta, Nicola Normanno, Antonella De Luca, Mario Mazzucato, Marta Celegato, Alfonso Colombatti and Donatella Aldinucci

    Version of Record online : 14 MAR 2013, DOI: 10.1002/jcb.24456

  5. You have free access to this content
    Suppression of liver regeneration and hepatocyte proliferation in hepatocyte-targeted glypican 3 transgenic mice

    Hepatology

    Volume 52, Issue 3, September 2010, Pages: 1060–1067, Bowen Liu, Aaron W. Bell, Shirish Paranjpe, William C. Bowen, Jaspal S. Khillan, Jian-Hua Luo, Wendy M. Mars and George K. Michalopoulos

    Version of Record online : 11 JUN 2010, DOI: 10.1002/hep.23794

  6. You have free access to this content
    A functional screening identifies five micrornas controlling glypican-3: role of mir-1271 down-regulation in hepatocellular carcinoma

    Hepatology

    Volume 57, Issue 1, January 2013, Pages: 195–204, Marion Maurel, Sandra Jalvy, Yannick Ladeiro, Chantal Combe, Laetitia Vachet, Francis Sagliocco, Paulette Bioulac-Sage, Vincent Pitard, Hélène Jacquemin-Sablon, Jessica Zucman-Rossi, Benoît Laloo and Christophe F. Grosset

    Version of Record online : 7 JAN 2013, DOI: 10.1002/hep.25994

  7. Identification of a Glypican-3-Binding Peptide for In Vivo Non-Invasive Human Hepatocellular Carcinoma Detection

    Macromolecular Bioscience

    Volume 17, Issue 4, April 2017, Zainen Qin, Jingjing Wang, Ye Wang, Guohao Wang, Xiangyu Wang, Zhiyang Zhou, Gang Liu, Shi Gao and Lei Zhu

    Version of Record online : 15 NOV 2016, DOI: 10.1002/mabi.201600335

  8. You have free access to this content
    Glypican-3 antibodies: A new therapeutic target for liver cancer

    FEBS Letters

    Volume 588, Issue 2, January 21, 2014, Pages: 377–382, Mingqian Feng and Mitchell Ho

    Version of Record online : 15 OCT 2013, DOI: 10.1016/j.febslet.2013.10.002

  9. You have full text access to this Open Access content
    Inhibition of tumor growth and sensitization to chemotherapy by RNA interference targeting interleukin-6 in the androgen-independent human prostate cancer PC3 model

    Cancer Science

    Volume 102, Issue 4, April 2011, Pages: 769–775, Iori Sakai, Hideaki Miyake, Tomoaki Terakawa and Masato Fujisawa

    Version of Record online : 11 FEB 2011, DOI: 10.1111/j.1349-7006.2011.01854.x

  10. You have free access to this content
    The oncofetal gene glypican 3 is regulated in the postnatal liver by zinc fingers and homeoboxes 2 and in the regenerating liver by alpha-fetoprotein regulator 2

    Hepatology

    Volume 46, Issue 5, November 2007, Pages: 1541–1547, Lorri A. Morford, Christina Davis, Lin Jin, Aneta Dobierzewska, Martha L. Peterson and Brett T. Spear

    Version of Record online : 1 AUG 2007, DOI: 10.1002/hep.21825

  11. Knockdown of GPC3 inhibits the proliferation of Huh7 hepatocellular carcinoma cells through down-regulation of YAP

    Journal of Cellular Biochemistry

    Volume 114, Issue 3, March 2013, Pages: 625–631, Hui-Lai Miao, Zhi-Jian Pan, Chang-Jiang Lei, Ji-Yu Wen, Ming-Yi Li, Zhong-Kao Liu, Zhi-Dong Qiu, Man-Zhou Lin, Nian-Ping Chen and Ming Chen

    Version of Record online : 22 JAN 2013, DOI: 10.1002/jcb.24404

  12. You have free access to this content
    Suppressed tumour growth and enhanced chemosensitivity by RNA interference targeting Aurora-A in the PC3 human prostate cancer model

    BJU International

    Volume 106, Issue 1, July 2010, Pages: 121–127, Masafumi Kumano, Hideaki Miyake, Tomoaki Terakawa, Junya Furukawa and Masato Fujisawa

    Version of Record online : 12 NOV 2009, DOI: 10.1111/j.1464-410X.2009.09047.x

  13. You have full text access to this OnlineOpen article
    Diminished expression of h2-calponin in prostate cancer cells promotes cell proliferation, migration and the dependence of cell adhesion on substrate stiffness

    FEBS Open Bio

    Volume 4, Issue 1, January 01, 2014, Pages: 627–636, M. Moazzem Hossain, Xin Wang, Raymond C. Bergan and J.-P. Jin

    Version of Record online : 24 JUN 2014, DOI: 10.1016/j.fob.2014.06.003

  14. You have free access to this content
    Pharmacological profile of phosphatidylinositol 3-kinases and related phosphatidylinositols mediating endothelinA receptor-operated native TRPC channels in rabbit coronary artery myocytes

    British Journal of Pharmacology

    Volume 166, Issue 7, August 2012, Pages: 2161–2175, J Shi, M Ju, WA Large and AP Albert

    Version of Record online : 9 JUL 2012, DOI: 10.1111/j.1476-5381.2012.01937.x

  15. Evaluation for clinical utility of GPC3, measured by a commercially available ELISA kit with Glypican-3 (GPC3) antibody, as a serological and histological marker for hepatocellular carcinoma

    Hepatology Research

    Volume 40, Issue 5, May 2010, Pages: 477–485, Eisuke Yasuda, Takashi Kumada, Hidenori Toyoda, Yuji Kaneoka, Atsuyuki Maeda, Seiji Okuda, Naoki Yoshimi and Osamu Kozawa

    Version of Record online : 30 MAR 2010, DOI: 10.1111/j.1872-034X.2010.00624.x

    Corrected by:

    Erratum

    Vol. 41, Issue 1, 101, Version of Record online: 30 DEC 2010

  16. HDAC1, HDAC4, and HDAC9 Bind to PC3/Tis21/Btg2 and Are Required for Its Inhibition of Cell Cycle Progression and Cyclin D1 Expression

    Journal of Cellular Physiology

    Volume 232, Issue 7, July 2017, Pages: 1696–1707, Laura Micheli, Giorgio D'Andrea, Luca Leonardi and Felice Tirone

    Version of Record online : 27 JAN 2017, DOI: 10.1002/jcp.25467

  17. Control of the Normal and Pathological Development of Neural Stem and Progenitor Cells by the PC3/Tis21/Btg2 and Btg1 Genes

    Journal of Cellular Physiology

    Volume 230, Issue 12, December 2015, Pages: 2881–2890, Laura Micheli, Manuela Ceccarelli, Stefano Farioli-Vecchioli and Felice Tirone

    Version of Record online : 24 AUG 2015, DOI: 10.1002/jcp.25038

  18. You have free access to this content
    Hepatocyte proliferation and hepatomegaly induced by phenobarbital and 1,4-bis [2-(3,5-dichloropyridyloxy)] benzene is suppressed in hepatocyte-targeted glypican 3 transgenic mice

    Hepatology

    Volume 54, Issue 2, August 2011, Pages: 620–630, Chih-Wen Lin, Wendy M. Mars, Shirish Paranjpe, Shashikiran Donthamsetty, Vishakha S. Bhave, Liang-I Kang, Anne Orr, William C. Bowen, Aaron W. Bell and George K. Michalopoulos

    Version of Record online : 25 JUL 2011, DOI: 10.1002/hep.24417

  19. You have free access to this content
    Platelet-Derived Growth Factor-D Overexpression Contributes to Epithelial-Mesenchymal Transition of PC3 Prostate Cancer Cells

    STEM CELLS

    Volume 26, Issue 6, June 2008, Pages: 1425–1435, Dejuan Kong, Zhiwei Wang, Sarah H. Sarkar, Yiwei Li, Sanjeev Banerjee, Allen Saliganan, Hyeong-Reh Choi Kim, Michael L. Cher and Fazlul H. Sarkar

    Version of Record online : 10 APR 2008, DOI: 10.1634/stemcells.2007-1076

  20. Characterization of the expression of variant and standard CD44 in prostate cancer cells: Identification of the possible molecular mechanism of CD44/MMP9 complex formation on the cell surface

    Journal of Cellular Biochemistry

    Volume 108, Issue 1, 1 September 2009, Pages: 272–284, B. Desai, T. Ma, J. Zhu and M.A. Chellaiah

    Version of Record online : 6 JUL 2009, DOI: 10.1002/jcb.22248